RSV season is ramping up, but some doctors are facing challenges getting ahold of a shot that can help protect young children.
RSV season is ramping up, and doctors are hoping a new shot to prevent the virus in young children will ease the caseload this year. However, some pediatricians are facing challenges getting supply. The CDC and FDA have approved the Beyfortus antibody shot, from drugmakers AstraZeneca and Sanofi, to prevent respiratory syncytial virus in babies from birth to 8 months old, or in children up to 24 months old with severe risk factors.
But for a lot of the insurance companies, it's dollars and cents.'Earlier in the summer, the American Academy of Pediatrics sent a letter to the CDC and the Centers for Medicare and Medicaid Services urging federal leaders to make sure the shot could be distributed widely and equitably. The CDC recently announced pediatricians will be able to get paid for counseling families about the drug in addition to administering the product.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
It shouldn’t be so hard for older adults to receive the RSV vaccineThe health-care system needs to eliminate barriers to adult RSV vaccination.
Read more »
Cleveland Clinic asks visitors to wear masks as RSV season beginsCourtney is a digital producer at News 5. She loves all things Cleveland and is a huge sports fan.
Read more »
This Could Be an RSV Season Like No Other, in a Good WayFor the first time, two preventive treatments are available that dramatically reduce the risk of severe RSV.
Read more »
Cold And Flu Season Is Coming: When To Test For Covid-19, Flu And RSVI’m the director of Clinical Virology and Vice Chair of Practice in the Department of Laboratory Medicine and Pathology at Mayo Clinic. I’m the past-President of the Pan American Society for Clinical Virology and specialize in the diagnosis of infectious diseases, such as Covid-19 and influenza. In 2020, my laboratory was one of the first in the United States to develop a molecular test to detect Covid-19. I specialize in infectious diseases and novel diagnostics to detect them.
Read more »
CHOP remained profitable, but barely, in fiscal 2023CHOP said last fall's triple-whammy of RSV, COVID-19, and the flu was a significant factor in the financial pressures during the year that ended June 30.
Read more »
When should you test for COVID? What if you're positive? Here's an explainerWith flu and RSV seasons set to soon heighten, when should you test for COVID if you are sick and how often?
Read more »